去泛素化酶 (DUB) 是一类蛋白酶,其功能是从与靶底物结合的前蛋白或泛素中裂解泛素 (Ub) 或泛素样蛋白。根据酶促裂解机制,DUB 分为两大类:半胱氨酸蛋白酶和锌金属蛋白酶。这些包括泛素特异性蛋白酶 (USP)、泛素 C 末端水解酶 (UCH)、卵巢肿瘤蛋白酶 (OTU)、Machado-Joseph 病蛋白酶 (MJD)、Jab1/Mov34/Mpr1 (JAMM) 金属蛋白酶和含有 MIU 的新型 DUB 家族 (MINDY) 蛋白酶。
泛素化是一种重要的翻译后修饰,在许多重要的细胞事件中起着关键作用。在此过程中,泛素通过 E1、E2 和 E3 酶的协同作用与底物蛋白结合,然后被 DUB 去除。因此,DUB 是 Ub 系统的重要调节剂,可调节大量细胞过程,包括蛋白质周转、蛋白质分选和运输。DUB 活性改变与多种病理有关,包括癌症。DUB 代表了靶向药物开发的新型候选药物。
Deubiquitinases (DUBs) are a family of proteases whose function is to cleave ubiquitin (Ub) or ubiquitin-like proteins from proproteins or ubiquitin(s) conjugated with target substrate. DUBs are divided into two main classes according to their enzymatic cleavage mechanism: cysteine proteases and zinc metalloproteases. These include ubiquitin-specific proteases (USPs), ubiquitin C-terminal hydrolases (UCHs), ovarian tumor proteases (OTUs), Machado-Joseph disease proteases (MJDs), Jab1/Mov34/Mpr1 (JAMM) metalloproteases, and MIU-containing novel DUB family, (MINDY) proteases.
Ubiquitination is an important post-translational modification that plays a key role in many vital cellular events. In this process, ubiquitin is attached to a substrate protein by the concerted action of an enzyme cascade involving E1, E2 and E3 enzymes and it is removed by DUBs. DUBs are therefore important regulators of the Ub system and regulate a plethora of cellular processes, including protein turnover, protein sorting, and trafficking. Altered DUB activity is associated with a multitude of pathologies including cancer. DUBs represent novel candidates for target-directed drug development.
CST967(Compound 17)是一种 USP7 PROTAC 降解剂,提高 PROTAC 浓度可加快 USP7 的降解速率,因此 CST967 可用于癌症研究(粉色:USP7 配体 (MS-V58330);蓝色:Cereblon 配体 (MS-B42308);黑色:连接子)。
MS8572 是一种选择性 OTUB1 共价配体,可共价修饰 OTUB1 的非催化半胱氨酸 23 残基而不抑制其去泛素化酶活性,并可用于开发靶向去泛素化酶的嵌合体以实现靶向蛋白稳定。
UBTR008295a 是一种 Kd 为 80 μM 的 USP5 ZnF-UBD 结合剂,可与 USP5 ZnF-UBD 发生相互作用,并可用于癌症研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号